Recursion Pharmaceuticals, Inc.
RXRXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Recursion Pharmaceuticals, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 7 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 22, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Tradition Wealth Management, LLC | 2026-03-31 | 67,738 | $208K | SEC filing |
| EFG International AG | 2026-03-31 | 1,500 | $4.61K | SEC filing |
| Keystone Financial Group | 2026-03-31 | 16,000 | $49.1K | SEC filing |
| KLP KAPITALFORVALTNING AS | 2026-03-31 | 97,500 | $299K | SEC filing |
| WHITTIER TRUST CO OF NEVADA INC | 2026-03-31 | 2,000 | $6.3K | SEC filing |
| Polymer Capital Management (US) LLC | 2026-03-31 | 39,883 | $122K | SEC filing |
| Green Alpha Advisors, LLC | 2026-03-31 | 152,098 | $467K | SEC filing |
| TUDOR INVESTMENT CORP ET AL | 2026-03-31 | 265,296 | $814K | SEC filing |
| Nan Fung Group Holdings Ltd | 2026-03-31 | 595,287 | $1.83M | SEC filing |
| NORTHERN TRUST CORP | 2026-03-31 | 3,968,411 | $12.2M | SEC filing |
| Values First Advisors, Inc. | 2026-03-31 | 74,236 | $228K | SEC filing |
| Sequoia Financial Advisors, LLC | 2026-03-31 | 15,162 | $46.5K | SEC filing |
| Private Wealth Asset Management, LLC | 2026-03-31 | 154 | $473 | SEC filing |
| HARBOUR INVESTMENTS, INC. | 2026-03-31 | 1,369 | $4.21K | SEC filing |
| STATE OF WISCONSIN INVESTMENT BOARD | 2026-03-31 | 248,011 | $761K | SEC filing |
| UBS Group AG | 2026-03-31 | 5,101,237 | $15.7M | SEC filing |
| PRUDENTIAL FINANCIAL INC | 2026-03-31 | 70,660 | $217K | SEC filing |
| HOEY INVESTMENTS, INC | 2026-03-31 | 1,000 | $3.07K | SEC filing |
| Cetera Investment Advisers | 2026-03-31 | 127,695 | $392K | SEC filing |
| Kestra Advisory Services, LLC | 2026-03-31 | 16,999 | $52.2K | SEC filing |
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Recursion Pharmaceuticals, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-03-03 · Borgeson Blake: Larger than 52 of the 56 other insider sales of Class A Common Stock on file. SEC filing
- 2026-02-03 · Borgeson Blake: Larger than 53 of the 56 other insider sales of Class A Common Stock on file. SEC filing
- 2026-01-06 · Borgeson Blake: Larger than 53 of the 56 other insider sales of Class A Common Stock on file. SEC filing
- 2025-12-02 · Borgeson Blake: Larger than 53 of the 56 other insider sales of Class A Common Stock on file. SEC filing
- 2025-08-11 · Gibson Christopher: Larger than all 56 other insider sales of Class A Common Stock on file. SEC filing
- 2025-03-27 · Gibson Christopher: Larger than 51 of the 56 other insider sales of Class A Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-18 | Bumpus Namandje · Director | Class A Common Stock | S — Open market or private sale | −3,963 | 3.18 | SEC filing |
| 2026-06-05 | Gibson Christopher · Director | Class A Common Stock | S — Open market or private sale | −40,000 | 3.62 | SEC filing |
| 2026-06-05 | Khan Najat · CEO and President | Class A Common Stock | S — Open market or private sale | −23,588 | 3.58 | SEC filing |
| 2026-06-03 | Bumpus Namandje · Director | Class A Common Stock | S — Open market or private sale | −4,386 | 3.54 | SEC filing |
| 2026-06-02 | Borgeson Blake · Director | Class A Common Stock | S — Open market or private sale | −30,000 | 3.68 | SEC filing |
| 2026-05-22 | Gibson Christopher · Director | Class A Common Stock | S — Open market or private sale | −40,000 | 3.08 | SEC filing |
| 2026-05-07 | Gibson Christopher · Director | Class A Common Stock | S — Open market or private sale | −40,000 | 3.37 | SEC filing |
| 2026-05-05 | Borgeson Blake · Director | Class A Common Stock | S — Open market or private sale | −30,000 | 3.52 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-17 | Sun Elaine D · Director | Class A Common Stock | A — Grant, award, or other acquisition | +88,424 | SEC filing |
| 2026-06-17 | Dar Zavain · Director | Class A Common Stock | A — Grant, award, or other acquisition | +88,424 | SEC filing |
| 2026-06-17 | Li Dean Y · Director | Class A Common Stock | A — Grant, award, or other acquisition | +88,424 | SEC filing |
| 2026-06-17 | Michor Franziska · Director | Class A Common Stock | A — Grant, award, or other acquisition | +88,424 | SEC filing |
| 2026-06-17 | Borgeson Blake · Director | Class A Common Stock | A — Grant, award, or other acquisition | +88,424 | SEC filing |
| 2026-06-17 | HERSHBERG ROBERT · Director | Class A Common Stock | A — Grant, award, or other acquisition | +88,424 | SEC filing |
| 2026-06-17 | Bumpus Namandje · Director | Class A Common Stock | A — Grant, award, or other acquisition | +88,424 | SEC filing |
| 2026-06-15 | Taylor Ben R · Chief Financial Officer | Class A Common Stock | F — Payment of exercise price or tax by delivering securities | −5,396 | SEC filing |
Showing 8 of 38 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.